Click image to view it in full size

The demand for outcomes based on evidence and value has encouraged the rapid adoption of Real World Evidence (RWE) IT Solutions towards application ranging from pharmaceutical R&D to commercial engagement and patient-centric treatment. The RWE IT Solutions market is still at a growth stage and continues to evolve through the data and technology advances adopted by the industry participants. Frost & Sullivan envisages the application for clinical development and commercial applications will continue to surge over the next five years. In addition, the evolving role of digital connected products and growth opportunities are highlighted in this study. Overall, we provide insights into the RWE IT Solutions ecosystem, preview of the participants and competitive landscape and growth opportunities, all elements essential for support stakeholders in their strategic decision journey.

Healthcare is rapidly transitioning to a patient-centric with focus on outcomes and value, while drug prices have increased and pharmaceutical R&D productivity is at its lowest. The healthcare industry and IT solutions providers are finding Real World Evidence as a potential solution to face these headwinds especially for the clinical development. The expansive data pools from public-private efforts coupled with emerging technologies such as Artificial Intelligence (AI), Cloud and other technologies is driving the growth of evidence based medicine.

The Transformational Health team at Frost & Sullivan provides critical insights into the US Real World Evidence IT Solutions market highlighting the key growth opportunities, market revenue forecast and trends that will play an important role in the growth of the industry. The study also highlights the technology trends, competitive environment and capability benchmarking of the selective market participants. RWE has become the focus for pharmaceutical and biotechnology companies, health technology Assessment Boards, The Food and Drug Administration (FDA) as well as Payers and Providers. In addition this report will be useful to the IT solutions providers, private investors, healthcare agencies and government bodies to understand the ecosystem, capability of the participants, revenue potential linked to the RWE IT Solutions market. The study identifies the largest revenue generating as well as the fastest growing application and service segment within the US RWE industry. Finally, with this research service, Frost & Sullivan’s Transformational Health group offers insightful analysis in the form of key growth opportunities that are centred on the application of AI for clinical trial data management, utilization of cloud for improving the commercial effectiveness, and connected digital products in clinical and post-market safety surveillance. Overall, this study will provide insightful into the RWE IT Solutions ecosystem, preview of the participants and competitive landscape and growth opportunities, all elements essential for support stakeholders in their strategic decision journey.